See the DrugPatentWatch profile for Humira

Humira is a widely used medication that is primarily prescribed to treat various autoimmune conditions such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, and plaque psoriasis. It belongs to a class of drugs known as biologics, specifically tumor necrosis factor (TNF) inhibitors. Humira works by targeting and blocking TNF, a protein that plays a crucial role in inflammation.

According to Drug Patent Watch, Humira was first approved by the U.S. Food and Drug Administration (FDA) in 2002 [1]. It is manufactured by AbbVie Inc., a global pharmaceutical company. Humira is available in the form of a subcutaneous injection, and it is typically administered every other week or once a week, depending on the condition being treated.

The official Humira website provides comprehensive information about the medication, including its indications, dosing instructions, potential side effects, and patient support resources [2]. It emphasizes the importance of consulting with a healthcare professional before starting Humira and offers a savings program to help eligible patients with the cost of the medication.

Humira Pro, another website provided, is a resource specifically designed for healthcare professionals. It offers in-depth information about Humira, including clinical trial data, safety information, dosing guidelines, and educational materials [3].

It is important to note that while Humira has been proven effective for many patients, it may not be suitable for everyone. As with any medication, there are potential side effects and risks associated with its use. Common side effects of Humira include injection site reactions, upper respiratory infections, and headaches. More serious side effects, although rare, may include serious infections, allergic reactions, and increased risk of certain types of cancer.

Patients considering Humira should discuss their medical history, current medications, and any concerns with their healthcare provider to determine if it is the right treatment option for them. Regular monitoring and follow-up with a healthcare professional are essential while taking Humira to ensure its continued effectiveness and to address any potential issues that may arise.

In conclusion, Humira is a widely used medication that is prescribed to treat various autoimmune conditions. It is a TNF inhibitor that works by targeting and blocking TNF, a protein involved in inflammation. Humira was first approved by the FDA in 2002 and is manufactured by AbbVie Inc. It is available as a subcutaneous injection and should be used under the guidance of a healthcare professional. While Humira has proven effective for many patients, it is important to be aware of potential side effects and risks associated with its use.

Sources:
[1] https://www.drugpatentwatch.com/p/biologics/tradename/HUMIRA
[2] https://www.humira.com/
[3] https://www.humirapro.com/